These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22426659)

  • 1. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease.
    Andican G; Konukoglu D; Bozluolcay M; Bayülkem K; Firtiına S; Burcak G
    Acta Neurol Belg; 2012 Jun; 112(2):155-9. PubMed ID: 22426659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson's disease? A comparison of Parkinson's disease patients, disease controls and healthy individuals.
    Song IU; Kim JS; Chung SW; Lee KS
    Eur Neurol; 2009; 62(2):99-104. PubMed ID: 19521085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris.
    Doo YC; Han SJ; Lee JH; Cho GY; Hong KS; Han KR; Lee NH; Oh DJ; Ryu KH; Rhim CY; Lee KH; Lee Y
    Am J Cardiol; 2004 Mar; 93(5):554-8. PubMed ID: 14996578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative damage in Parkinson disease: Measurement using accurate biomarkers.
    Seet RC; Lee CY; Lim EC; Tan JJ; Quek AM; Chong WL; Looi WF; Huang SH; Wang H; Chan YH; Halliwell B
    Free Radic Biol Med; 2010 Feb; 48(4):560-6. PubMed ID: 19969070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
    White M; Ducharme A; Ibrahim R; Whittom L; Lavoie J; Guertin MC; Racine N; He Y; Yao G; Rouleau JL; Schiffrin EL; Touyz RM
    Clin Sci (Lond); 2006 Apr; 110(4):483-9. PubMed ID: 16402915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.
    Zhang YC; Wei JJ; Wang F; Chen MT; Zhang MZ
    Cell Biochem Biophys; 2012 Mar; 62(2):365-72. PubMed ID: 21947962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
    Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
    Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension.
    Tousoulis D; Zisimos K; Antoniades C; Stefanadi E; Siasos G; Tsioufis C; Papageorgiou N; Vavouranakis E; Vlachopoulos C; Stefanadis C
    Int J Cardiol; 2009 Aug; 136(3):258-62. PubMed ID: 18657327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
    Pawlak K; Mysliwiec M; Pawlak D
    Life Sci; 2013 Mar; 92(4-5):253-8. PubMed ID: 23295961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood markers of oxidative stress in Parkinson's disease.
    Younes-Mhenni S; Frih-Ayed M; Kerkeni A; Bost M; Chazot G
    Eur Neurol; 2007; 58(2):78-83. PubMed ID: 17565220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease.
    Baran A; Bulut M; Kaya MC; Demirpençe Ö; Sevim B; Akıl E; Varol S
    Neurol Sci; 2019 Jan; 40(1):167-173. PubMed ID: 30353300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte vitamin C levels as potential biomarker for progression of Parkinson's disease.
    Ide K; Yamada H; Umegaki K; Mizuno K; Kawakami N; Hagiwara Y; Matsumoto M; Yoshida H; Kim K; Shiosaki E; Yokochi T; Harada K
    Nutrition; 2015 Feb; 31(2):406-8. PubMed ID: 25592020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys.
    Miklossy J; Doudet DD; Schwab C; Yu S; McGeer EG; McGeer PL
    Exp Neurol; 2006 Feb; 197(2):275-83. PubMed ID: 16336966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease.
    Umemura A; Oeda T; Yamamoto K; Tomita S; Kohsaka M; Park K; Sugiyama H; Sawada H
    PLoS One; 2015; 10(8):e0136722. PubMed ID: 26308525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis.
    Côté N; Pibarot P; Pépin A; Fournier D; Audet A; Arsenault B; Couture C; Poirier P; Després JP; Mathieu P
    Int J Cardiol; 2010 Dec; 145(3):444-9. PubMed ID: 19525020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress markers are increased since early stages of infection in syphilitic patients.
    Hébert-Schuster M; Borderie D; Grange PA; Lemarechal H; Kavian-Tessler N; Batteux F; Dupin N
    Arch Dermatol Res; 2012 Nov; 304(9):689-97. PubMed ID: 23011658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease.
    Chen CM; Liu JL; Wu YR; Chen YC; Cheng HS; Cheng ML; Chiu DT
    Neurobiol Dis; 2009 Mar; 33(3):429-35. PubMed ID: 19110057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa.
    Agil A; Durán R; Barrero F; Morales B; Araúzo M; Alba F; Miranda MT; Prieto I; Ramírez M; Vives F
    J Neurol Sci; 2006 Jan; 240(1-2):31-6. PubMed ID: 16219327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.